300 mg once daily
Context: randomized insomnia-symptom trial PMCID PMC6031986
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.